CI Investments Inc
BHVN

CI Investments Inc’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

CI Investments Inc’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-90
Closed -$14K – 1447
2022
Q3 		$14K Sell
90
-2
-2% -$296 ﹤0.01% 1100
2022
Q2 		$13K Sell
92
-194
-68% -$24.8K ﹤0.01% 1026
2022
Q1 		$34K Sell
286
-23
-7% -$2.87K ﹤0.01% 1017
2021
Q4 		$43K Sell
309
-4,220
-93% -$537K ﹤0.01% 1023
2021
Q3 		$629K Buy
+4,529
New +$565K ﹤0.01% 543
2021
Q1 		– Sell
-6,072
Closed -$520K – 1082
2020
Q4 		$520K Buy
+6,072
New +$515K ﹤0.01% 498

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

CI Investments Inc's BHVN Position: Q4 2022 in Review

CI Investments Inc sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 90 shares — an estimated $14K sold.

CI Investments Inc first reported a position in BHVN in Q4 2020 and held it in 6 quarters. The position peaked at $629K in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • CI Investments Inc reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • CI Investments Inc sold 90 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $14K.
  • CI Investments Inc first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020 and held it in 6 quarters.
  • CI Investments Inc's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $629K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on CI Investments Inc's 13F filing for Q4 2022, filed 10 Feb 2023.